Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03189329
Other study ID # PYO.TIP.1904.15.009
Secondary ID
Status Completed
Phase Phase 4
First received June 10, 2017
Last updated June 14, 2017
Start date January 2015
Est. completion date January 2016

Study information

Verified date June 2017
Source Ondokuz Mayis University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators measured changes in cerebral oxygen saturation (rSO2) and MMSE scores after retrobulbar block performed with levobupivacaine and lidocaine in patients undergoing vitreoretinal surgery.A total of 66 patients over the age of 60 undergoing vitreoretinal surgery with a total duration of less than 1 hour were included in this prospective, double-blinded study. The patients were randomly divided into two groups: group L (5ml, 2% lidocaine) and group LB (5ml, 0.5% levobupivacaine). Bilateral rSO2 measurements were recorded before the retrobulbar block and at 1-5 minutes post-block, during the procedure, and at 10-40 minutes post-op. MMSE was performed preoperatively and postoperatively in order to evaluate short term cognitive function. Sensory and motor block durations, pain, akinesia and conjunctival feeling scores, patient-surgeon satisfaction, and complications were also recorded.


Description:

A total of 66 patients undergoing vitreoretinal surgery (total duration < 60 minutes) using retrobulbar block, who were classified as category I-III according to the ASA (American Society of Anesthesiologists) Classification system, who were over the age of 60, and who had no cognitive dysfunction were included in the study. Exclusion criteria were as follows: contraindication for retrobulbar block, preoperative systolic blood pressure of 180 mmHg, diastolic blood pressure of above 100 mmHg, uncontrolled diabetes, body mass index ≥ 30 kg/m2, MMSE ≤ 24, advanced organ failure, or Hb < 9gr/dl.The patients were randomly divided into two groups using a sealed-envelope method:

Group L: Patients undergoing block with lidocaine (n = 33) Group LB: Patients undergoing block with levobupivacaine (n = 33) The patients did not undergo premedication in order to accommodate the postoperative MMSE evaluation. For intra-operative sedation, remifentanil (UltivaR, GlaxoSmithKline, Berntford, UK) was initiated as an infusion at a dose range of 0.05-0.1 mcg/kg/min. The mean arterial pressure and heart rate values were allowed to vary up to 20% of the preoperative values of the patients. For this purpose, the remifentanil infusion rate was increased or decreased at the determined dose interval.

Retrobulbar block was performed with 5 ml of 2% lidocaine hydrochloride (AritmalR, Osel, Istanbul, Turkey) in Group L patients and 5ml of 0.5% levobupivacaine (ChirocaineR, Abbvie, Chicago, USA) in Group LB patients. The block was performed by the same practitioner (fourth year assistant of Ophthalmology Department) using inferotemporal approach as described by Sanderson using 27 gage disposable needles (Atkinson Retrobulbar NeedleR, Asico, USA).

Sensory and motor block onset and end times and akinesia score were recorded. The mean arterial pressure (MAP), heart rate (HR), and oxygen saturation (SpO2) were recorded in the preoperative period, at minutes 1, 3, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 intra-operatively, and at 10, 20, 30, and 40 minutes postoperatively in the recovery room.

. The patients were transferred to the operating table for measurement of bilateral rSO2, and preoxygenation was performed for three minutes using 4 L/min 100% oxygen via nasal cannula. The basal oxygenation values were determined by taking the average of the last 30 s measurements. The rSO2 values were recorded at 1, 3, 5, 10, 15, 20, 25, 30th, 35, 40, 45, 50, 55, and 60 minutes after retrobulbar block, and at 10, 20, 30, and 40 minutes after the completion of the procedure.

Cognitive functions were assessed by the same technician using MMSE in the preoperative period, 40 minutes postoperatively and at 7 days after the operation (short term).Surgeon satisfaction was queried at the end of the case and patient satisfaction was questioned at the end of day.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

- Undergoing vitreoretinal surgery (total duration < 60 minutes)

- The ASA (American Society of Anesthesiologists) Classification I-III

- Over the age of 60

- The patiens who had no cognitive dysfunction

Exclusion Criteria:

- Contraindication for retrobulbar block

- Preoperative systolic blood pressure of 180 mmHg, diastolic blood pressure of above 100 mmHg

- Uncontrolled diabetes

- Body mass index = 30 kg/m2

- MMSE = 24

- Advanced organ failure

- Hb < 9gr/dl

Study Design


Intervention

Drug:
2% lidocaine hydrochloride
Retrobulbar block was performed with 5 ml of 2% lidocaine hydrochloride (AritmalR, Osel, Istanbul, Turkey) in Group L patients. The block was performed by the same practitioner (fourth year assistant of Ophthalmology Department) using inferotemporal approach as described by Sanderson using 27 gage disposable needles (Atkinson Retrobulbar NeedleR, Asico, USA)
0.5% levobupivacaine
and 5ml of 0.5% levobupivacaine (ChirocaineR, Abbvie, Chicago, USA) in Group LB patients. The block was performed by the same practitioner (fourth year assistant of Ophthalmology Department) using inferotemporal approach as described by Sanderson using 27 gage disposable needles (Atkinson Retrobulbar NeedleR, Asico, USA)

Locations

Country Name City State
Turkey Ondokuz Mayis Universitesi Samsun Atakum

Sponsors (2)

Lead Sponsor Collaborator
Cengiz KAYA Ondokuz Mayis University

Country where clinical trial is conducted

Turkey, 

References & Publications (21)

Aksu R, Bicer C, Ozkiris A, Akin A, Bayram A, Boyaci A. Comparison of 0.5% levobupivacaine, 0.5% bupivacaine, and 2% lidocaine for retrobulbar anesthesia in vitreoretinal surgery. Eur J Ophthalmol. 2009 Mar-Apr;19(2):280-4. — View Citation

Astrup J. Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy. J Neurosurg. 1982 Apr;56(4):482-97. Review. — View Citation

Baik JS, Sohn JT, Ok SH, Kim JG, Sung HJ, Park SS, Park JY, Hwang EM, Chung YK. Levobupivacaine-induced contraction of isolated rat aorta is calcium dependent. Can J Physiol Pharmacol. 2011 Jul;89(7):467-76. doi: 10.1139/Y11-046. Epub 2011 Jul 21. — View Citation

Birt DJ, Cummings GC. The efficacy and safety of 0.75% levobupivacaine vs 0.75% bupivacaine for peribulbar anaesthesia. Eye (Lond). 2003 Mar;17(2):200-6. — View Citation

BOBERG-ANS J. Experience in clinical examination of corneal sensitivity; corneal sensitivity and the naso-lacrimal reflex after retrobulbar anaesthesia. Br J Ophthalmol. 1955 Dec;39(12):705-26. — View Citation

Casati A, Fanelli G, Pietropaoli P, Proietti R, Tufano R, Montanini S; Collaborative Italian Study Group on Anaesthesia in Elderly Patients, Danelli G, Nuzzi M, Mentegazzi F, Torri G, Martani C, Spreafico E, Fierro G, Pugliese F, De Cosmo G, Aceto P, Servillo G, Monaco F. Monitoring cerebral oxygen saturation in elderly patients undergoing general abdominal surgery: a prospective cohort study. Eur J Anaesthesiol. 2007 Jan;24(1):59-65. Epub 2006 Jul 7. — View Citation

Ghali AM. The efficacy of 0.75% levobupivacaine versus 0.75% ropivacaine for peribulbar anesthesia in vitreoretinal surgery. Saudi J Anaesth. 2012 Jan;6(1):22-6. doi: 10.4103/1658-354X.93050. — View Citation

Haschke RH, Fink BR. Lidocaine effects on brain mitochondrial metabolism in vitro. Anesthesiology. 1975 Jun;42(6):737-40. — View Citation

Kim MN, Durduran T, Frangos S, Edlow BL, Buckley EM, Moss HE, Zhou C, Yu G, Choe R, Maloney-Wilensky E, Wolf RL, Grady MS, Greenberg JH, Levine JM, Yodh AG, Detre JA, Kofke WA. Noninvasive measurement of cerebral blood flow and blood oxygenation using nea — View Citation

Murphy PJ, Lawrenson JG, Patel S, Marshall J. Reliability of the non-contact corneal aesthesiometer and its comparison with the Cochet-Bonnet aesthesiometer. Ophthalmic Physiol Opt. 1998 Nov;18(6):532-9. — View Citation

Pacella E, Collini S, Pacella F, Piraino DC, Santamaria V, De Blasi RA. Levobupivacaine vs. racemic bupivacaine in peribulbar anaesthesia: a randomized double blind study in ophthalmic surgery. Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):539-44. — View Citation

Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol. 2001 Dec;58(12):1985-92. Review. — View Citation

Rasool N, Faroqui M, Rubinstein EH. Lidocaine accelerates neuroelectrical recovery after incomplete global ischemia in rabbits. Stroke. 1990 Jun;21(6):929-35. — View Citation

Ripart J, Lefrant JY, Vivien B, Charavel P, Fabbro-Peray P, Jaussaud A, Dupeyron G, Eledjam JJ. Ophthalmic regional anesthesia: medial canthus episcleral (sub-tenon) anesthesia is more efficient than peribulbar anesthesia: A double-blind randomized study. Anesthesiology. 2000 May;92(5):1278-85. — View Citation

Shokunbi MT, Gelb AW, Wu XM, Miller DJ. Continuous lidocaine infusion and focal feline cerebral ischemia. Stroke. 1990 Jan;21(1):107-11. — View Citation

Simonson D. Retrobulbar block: a review for the clinician. AANA J. 1990 Dec;58(6):456-61. Review. — View Citation

Suehiro K, Okutai R. Duration of cerebral desaturation time during single-lung ventilation correlates with mini mental state examination score. J Anesth. 2011 Jun;25(3):345-9. doi: 10.1007/s00540-011-1136-1. Epub 2011 Apr 12. — View Citation

Sung HJ, Ok SH, Sohn JY, Son YH, Kim JK, Lee SH, Han JY, Lim DH, Shin IW, Lee HK, Chung YK, Choi MJ, Sohn JT. Vasoconstriction potency induced by aminoamide local anesthetics correlates with lipid solubility. J Biomed Biotechnol. 2012;2012:170958. doi: 10 — View Citation

Tsai TC, Orav EJ, Jha AK. Patient satisfaction and quality of surgical care in US hospitals. Ann Surg. 2015 Jan;261(1):2-8. doi: 10.1097/SLA.0000000000000765. — View Citation

Wang PW, Chen ML, Huang LW, Yang W, Wu KY, Huang YF. Prenatal nonylphenol exposure, oxidative and nitrative stress, and birth outcomes: A cohort study in Taiwan. Environ Pollut. 2015 Dec;207:145-51. doi: 10.1016/j.envpol.2015.08.044. Epub 2015 Sep 12. — View Citation

Zhang Y, Qian Y, Bao H, Shi H, Zhou J. [Effect of Stellate Ganglion Block on Bilateral Regional Cerebral Oxygen Saturation and Postoperative Cognitive Function]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2016 Feb;33(1):132-5. Chinese. — View Citation

* Note: There are 21 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Cerebral oxygen saturation changes (rSO2) The NIRS device probes (INVOS-3100AR; Somanetics Inc., Troy, MI, USA) were placed at least 2 cm above the eyebrows and 3 cm away from the mid-line of the forehead, on right and left, in accordance with the instructions of manufacturer.The patient's forehead was cleaned with acetone alcohol before the sensor pads were glued, and wrapped with a bandage so that the sensors were not affected by ambient light. The patients were transferred to the operating table for measurement of bilateral rSO2, and preoxygenation was performed for three minutes using 4 L/min 100% oxygen via nasal cannula. The rSO2 value changes were recorded from baseline up to 40 minutes after surgery
Secondary Cognitive function measurement Cognitive functions were assessed by the same technician using the Mini Mental State Examination (MMSE) test. Cognitive functions were assessed from baseline up to 7 days after the surgery
Secondary Sensory block onset time by the conjunctival feeling score using the cotton contact test. The sensory block onset time was recorded as the moment when the patient did not feel a piece of cotton touching the cornea. This time was measured by the conjunctival feeling score using the cotton contact test (0: normal, 1: less sensitive, 2: complete sensory loss). Score of 2 on the scale was considered as onset time for sensory block. The sensory block onset time was recorded at the beginning of surgery till the first 15 min
Secondary Sensory block end time by the conjunctival feeling score using the cotton contact test. The time at which recovery of sensory block was recovered was measured by the conjunctival feeling score using the cotton contact test (0: normal, 1: less sensitive, 2: complete sensory loss). Score of 0 on the scale was considered as end time for sensory block. The sensory block end time was recorded at the end of surgery till the first 24 h
Secondary Motor block onset time by eye movements score. The motor block onset time was recorded as the time that the patient's eye movements score was four or less. Eye movements score was measured over three points in each of the four quadrants as follows: 3, full eye movement and 0, no movement. The motor block onset time was recorded at the beginning of surgery till the first 15 min
Secondary Motor block end time by eye movements score. The time at which recovery of motor block was recovered was measured by the eye movements score (three points in each of the four quadrants as follows: 3, full eye movement and 0, no movement). Score of 12 on the scale was considered as end time for motor block. The motor block end time was recorded at the end of surgery till the first 24 h
Secondary The akinesia score measurement The akinesia score was assessed between 0-12 points after 10 minutes of block application. Eye movements were measured over three points in each of the four quadrants as follows: 3, full eye movement and 0, no movement. The sum of the movement scores across all four quadrants was recorded as the akinesian score. An eye with full movement was scored as 12, and an immobile eye was scored as 0. If the akinesia score was four or less, the block was considered successful. The akinesia score was assessed at the beginning of surgery till the first 15 min.
Secondary The mean arterial pressure (MAP) measurement The mean arterial pressure (MAP) was recorded in the preoperative period, at minutes 1, 3, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 intra-operatively, and at 10, 20, 30, and 40 minutes postoperatively in the recovery room. The mean arterial pressure was recorded from baseline up to 40 minutes after surgery
Secondary The heart rate (HR) measurement The heart rate (HR) was recorded in the preoperative period, at minutes 1, 3, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 intra-operatively, and at 10, 20, 30, and 40 minutes postoperatively in the recovery room. The heart rate (HR) was recorded from baseline up to 40 minutes after surgery
Secondary The oxygen saturation (SpO2) measurement The oxygen saturation (SpO2) was recorded in the preoperative period, at minutes 1, 3, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 intra-operatively, and at 10, 20, 30, and 40 minutes postoperatively in the recovery room. The oxygen saturation (SpO2) was recorded from baseline up to 40 minutes after surgery
Secondary Surgeon satisfaction They were asked to score over 10 point scale. Surgeon satisfaction was evaluated using 10 point scale ( 0 = not satisfied at all and 10 = very satisfied) Surgeon satisfaction was queried at the end of the surgery till the first 15 min.
Secondary Patient satisfaction They were asked to score over 10 point scale. Patient satisfaction was evaluated using 10 point scale ( 0 = not satisfied at all and 10 = very satisfied) Patient satisfaction was questioned 24 hours after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03221452 - Adaptation of a Cognitive Training Intervention for Diabetes Self-Management N/A
Not yet recruiting NCT06102967 - EEG Characteristics and Postoperative Delirium
Recruiting NCT06217887 - Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients N/A
Suspended NCT05773430 - The Targeted Neurocognitive Training (TNT) Study N/A
Recruiting NCT05694039 - A Prospective Cohort Study On Change of Cognitive Function In Aged-related Hearing Loss With Hearing Aids N/A
Withdrawn NCT04563234 - Perioperative Cognitive Training in Thoracic Surgery N/A
Recruiting NCT05598047 - Executive Functioning Training Study Phase 2
Completed NCT05990335 - Boost Study 21270 (Cognition) Early Phase 1
Terminated NCT04101006 - Perioperative Changes of Cerebrovascular Autoregulation and Association With Cognitive Function